Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-06
2000-03-07
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514343, 514422, 514426, 546114, 5462764, 548557, C07D40102, A61K 3140, A61K 31435
Patent
active
060340932
ABSTRACT:
The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
REFERENCES:
patent: 5612353 (1997-03-01), Ewing et al.
patent: 5731315 (1998-03-01), Ewing et al.
Becker Michael R.
Choi-Sledeski Yong Mi
Davis Roderick S.
Ewing William R.
McGarry Daniel G.
Davis Zinna Northington
Oehler Rose J.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
LandOfFree
Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azah does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azah, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azah will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363411